Genentech's alternative to breakthrough committee

WASHINGTON - Genentech Inc. last week proposed to members of Congress that the Clinton administration's breakthrough drugs committee be abandoned in favor of technology assessment activities that would do a better job of accommodating the funding and development of improved medical technologies.

At a hearing of the House subcommittee on technology, environment and

Read the full 520 word article

How to gain access

Continue reading with a
two-week free trial.